Citigroup’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $155M | Buy |
2,561,350
+183,928
| +8% | +$10.7M | 0.07% | 270 |
|
|
2025
Q4 | $128M | Sell |
2,377,422
-330,471
| -12% | -$15.9M | 0.06% | 297 |
|
|
2025
Q3 | $122M | Sell |
2,707,893
-909,495
| -25% | -$42.5M | 0.05% | 331 |
|
|
2025
Q2 | $167M | Buy |
3,617,388
+688,470
| +24% | +$33.8M | 0.08% | 232 |
|
|
2025
Q1 | $179M | Buy |
2,928,918
+510,648
| +21% | +$29.8M | 0.09% | 200 |
|
|
2024
Q4 | $137M | Sell |
2,418,270
-434,342
| -15% | -$24.3M | 0.08% | 219 |
|
|
2024
Q3 | $148M | Buy |
2,852,612
+12,912
| +0.5% | +$606K | 0.09% | 205 |
|
|
2024
Q2 | $118M | Sell |
2,839,700
-326,908
| -10% | -$14.6M | 0.08% | 225 |
|
|
2024
Q1 | $172M | Sell |
3,166,608
-299,647
| -9% | -$15.3M | 0.11% | 163 |
|
|
2023
Q4 | $178M | Sell |
3,466,255
-222,414
| -6% | -$11.7M | 0.13% | 144 |
|
|
2023
Q3 | $214M | Sell |
3,688,669
-127,716
| -3% | -$7.83M | 0.16% | 99 |
|
|
2023
Q2 | $244M | Sell |
3,816,385
-1,083,808
| -22% | -$72.7M | 0.16% | 94 |
|
|
2023
Q1 | $340M | Sell |
4,900,193
-1,522,465
| -24% | -$107M | 0.24% | 61 |
|
|
2022
Q4 | $462M | Buy |
6,422,658
+714,035
| +13% | +$53.8M | 0.37% | 41 |
|
|
2022
Q3 | $406M | Buy |
5,708,623
+893,704
| +19% | +$64.8M | 0.29% | 49 |
|
|
2022
Q2 | $371M | Sell |
4,814,919
-133,992
| -3% | -$10.2M | 0.28% | 51 |
|
|
2022
Q1 | $361M | Sell |
4,948,911
-1,533,513
| -24% | -$103M | 0.22% | 68 |
|
|
2021
Q4 | $404M | Buy |
6,482,424
+2,727,957
| +73% | +$160M | 0.22% | 72 |
|
|
2021
Q3 | $222M | Sell |
3,754,467
-106,397
| -3% | -$7.01M | 0.13% | 130 |
|
|
2021
Q2 | $258M | Sell |
3,860,864
-213,570
| -5% | -$13.9M | 0.16% | 122 |
|
|
2021
Q1 | $257M | Sell |
4,074,434
-62,506
| -2% | -$3.89M | 0.17% | 114 |
|
|
2020
Q4 | $257M | Buy |
4,136,940
+673,181
| +19% | +$41.4M | 0.15% | 120 |
|
|
2020
Q3 | $209M | Buy |
3,463,759
+369,198
| +12% | +$22.2M | 0.14% | 119 |
|
|
2020
Q2 | $182M | Buy |
3,094,561
+192,537
| +7% | +$11.5M | 0.14% | 121 |
|
|
2020
Q1 | $162M | Sell |
2,902,024
-552,474
| -16% | -$33.8M | 0.15% | 107 |
|
|
2019
Q4 | $222M | Sell |
3,454,498
-2,557,835
| -43% | -$146M | 0.16% | 115 |
|
|
2019
Q3 | $305M | Buy |
6,012,333
+3,707,678
| +161% | +$174M | 0.24% | 62 |
|
|
2019
Q2 | $105M | Sell |
2,304,655
-2,433,856
| -51% | -$113M | 0.08% | 218 |
|
|
2019
Q1 | $226M | Buy |
4,738,511
+2,400,984
| +103% | +$120M | 0.22% | 72 |
|
|
2018
Q4 | $122M | Buy |
2,337,527
+247,258
| +12% | +$13.3M | 0.12% | 146 |
|
|
2018
Q3 | $130M | Buy |
2,090,269
+200,889
| +11% | +$11.9M | 0.12% | 146 |
|
|
2018
Q2 | $105M | Sell |
1,889,380
-77,239
| -4% | -$4.17M | 0.1% | 166 |
|
|
2018
Q1 | $124M | Buy |
1,966,619
+54,596
| +3% | +$3.51M | 0.1% | 158 |
|
|
2017
Q4 | $117M | Sell |
1,912,023
-14,705
| -0.8% | -$920K | 0.09% | 197 |
|
|
2017
Q3 | $123M | Buy |
1,926,728
+192,010
| +11% | +$11.2M | 0.1% | 157 |
|
|
2017
Q2 | $96.7M | Sell |
1,734,718
-64,618
| -4% | -$3.52M | 0.09% | 180 |
|
|
2017
Q1 | $97.8M | Sell |
1,799,336
-197,040
| -10% | -$10.8M | 0.09% | 181 |
|
|
2016
Q4 | $117M | Buy |
1,996,376
+816,401
| +69% | +$44.6M | 0.11% | 169 |
|
|
2016
Q3 | $63.6M | Buy |
1,179,975
+76,615
| +7% | +$4.92M | 0.06% | 280 |
|
|
2016
Q2 | $81.2M | Sell |
1,103,360
-38,845
| -3% | -$2.74M | 0.08% | 226 |
|
|
2016
Q1 | $73M | Buy |
1,142,205
+128,381
| +13% | +$8.1M | 0.08% | 224 |
|
|
2015
Q4 | $69.7M | Sell |
1,013,824
-421,682
| -29% | -$27.9M | 0.07% | 261 |
|
|
2015
Q3 | $85M | Sell |
1,435,506
-308,017
| -18% | -$19.5M | 0.08% | 201 |
|
|
2015
Q2 | $116M | Buy |
1,743,523
+522,858
| +43% | +$34.5M | 0.1% | 170 |
|
|
2015
Q1 | $78.7M | Sell |
1,220,665
-883,722
| -42% | -$55.3M | 0.08% | 240 |
|
|
2014
Q4 | $124M | Buy |
2,104,387
+489,945
| +30% | +$27.6M | 0.11% | 175 |
|
|
2014
Q3 | $82.6M | Sell |
1,614,442
-478,006
| -23% | -$23.9M | 0.07% | 243 |
|
|
2014
Q2 | $102M | Buy |
2,092,448
+667,915
| +47% | +$32.9M | 0.1% | 184 |
|
|
2014
Q1 | $74M | Sell |
1,424,533
-3,248,575
| -70% | -$173M | 0.08% | 215 |
|
|
2013
Q4 | $248M | Buy |
4,673,108
+2,505,139
| +116% | +$128M | 0.22% | 62 |
|
|
2013
Q3 | $100M | Sell |
2,167,969
-2,603
| -0.1% | -$114K | 0.09% | 185 |
|
|
2013
Q2 | $97M | Buy |
+2,170,572
| New | +$94.2M | 0.1% | 158 |
|
Other funds holding BMY
VCM
VPM
Citigroup's BMY Position: Q1 2026 in Review
Citigroup increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2026, buying an estimated $10.7M and bringing the position to 2,561,350 shares worth $155M. The position accounts for 0.07% of the portfolio, ranked #270.
Citigroup first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $462M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citigroup held 2,561,350 shares of Bristol-Myers Squibb worth $155M as of Q1 2026.
- Citigroup bought 183,928 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.7M.
- Bristol-Myers Squibb made up 0.07% of Citigroup's portfolio in Q1 2026, its #270 holding.
- Citigroup first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Bristol-Myers Squibb position peaked at $462M in Q4 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.